Skip to main content

Table 4 COVID-19 vaccine type and injection method (N = 23)

From: A follow-up report on the published paper Social and clinical impact of COVID-19 on patients with fibrodysplasia ossificans progressiva

Manufacturer

Number of subjects

Frequency (%)

Pfizer

16

69.5

Johnson & Johnson

3

13

Moderna

3

13

CoronaVac

1

4.3

Injection location

Number of subjects

Frequency (%)

Intramuscular

20

86.9

Subcutaneous

1

4.3

Mixed

11

4.3

Not reported

1

4.3

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172